Skip to content

Clinical Study to Evaluate The Efficacy Of Higher Potency Repetition Against Same Potency Repetition Of Homoeopathic Medicine in Choronic Sickness

A Prospective, Randomized, Single Blind, Four Arm Clinical Study to Evaluate the Efficacy of Higher Potency Repetition Against Same Potency Repetition of Individualised Homoeopathic Medicine Having Alternating Action on Non-Improving Patients with Chronic Sickness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042880
Enrollment
80
Registered
2022-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D599- Acquired hemolytic anemia, unspecified Health Condition 2: L209- Atopic dermatitis, unspecified Health Condition 3: K804- Calculus of bile duct with cholecystitis Health Condition 4: K739- Chronic hepatitis, unspecified Health Condition 5: J449- Chronic obstructive pulmonary disease, unspecified Health Condition 6: J310- Chronic rhinitis Health Condition 7: J329- Chronic sinusitis, unspecified Health Condition 8: I10- Essential (primary) hypertension Health Condition 9:

Interventions

Intervention1: Arnica montana, Arsenicum album, Belladonna, Bryonia alba, Chamomilla, China officinalis, Digitalis purpura, Hyoscyamusnigre, Ignatiaamara, Magnespolusambu, Manganumaceticum, Menyanthes
Post Hahnemannian Stalwarts are not included). If the prescriber of these medicines (selected on strict Homoeopathic principles) finds that no improvement follows, he should repeat the same medicine i

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients prescribed medicines having alternating action (17 Medicines), in Centesimal Scale or LM Scale on Pre-Screening Visit and no improvement reported on next visit (Screening Visit). Patients from different socio-economic status. Patients willing to participate in the study. Patient with chronic complaints.

Exclusion criteria

Exclusion criteria: Patient suffering from any life threatening disease. Patients having very poor general condition. Patient not willing to participate in the study. Patients with acute complaints. Patients with Decimal Scale or Mother Tinctures Patients who have received any homoeopathic medicine within last 3 months.

Design outcomes

Primary

MeasureTime frame
Improvement in in main complaint, Overall coping with the disorder and Overall well beingTimepoint: Day 1 (Screening visit), 15, 30 and Day 45 (End of the study visit)

Secondary

MeasureTime frame
superiority of Centicimal potency against LM Potency of the indicated homoeopathic medication having alternating action on non-improving chronic patientsTimepoint: Day 1 (Screening visit), 15, 30 and Day 45 (End of the study visit)

Countries

India

Contacts

Public ContactDr Ashutosh Tripathi

Parul University, Vadodara Gujarat

rakesh.gohel@paruluniversity.ac.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026